Skip to main content
. 2018 Nov 16;150(6):733–794. doi: 10.1007/s00418-018-1753-y

Table 5.

Organizations regulating and coordinating nanomedical translational work

EMA European Medicines Agency https://www.ema.europa.eu/
ETPN European Technology Platform for Nanomedicine: established the first European Translational Advisory Board https://etp-nanomedicine.eu/
ERC European Research Council https://erc.europa.eu/
FDA US Food & Drug Administration https://www.fda.gov/
NNI National Nanotechnology Initiative https://www.nano.gov/
Health Canada Health Canada https://www.canada.ca/en/health-canada.html
NINT National Institute for Nanotechnology http://www.nint-innt.ca/
PMDA Pharmaceuticals and Medical Devices Agency https://www.pmda.go.jp/english/
JST Japan Science and Technology Agency https://www.jst.go.jp/EN/
TGA Therapeutic Goods Administration; Australian Government Departmen of Health https://www.tga.gov.au/
ANN Australian Nanotechnology Network http://www.ausnano.net/
CFDA China Food and Drug Administration http://eng.sfda.gov.cn/
NanoCTR National Center for Nanoscience and Technology http://english.nanoctr.cas.cn/